
Access & Impact
Viatris Publishes 2024 Sustainability Report: Building Sustainable Access at Scale

Discover Viatris
Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook

Discover Viatris
Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential

Discover Viatris